
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NEIL1 CRISPR/Cas9 KO Plasmid (h) | sc-403778 | 20 µg | $397.00 |
NEIL1 (endonuclease VIII-like 1) is a DNA glycosylase/AP lyase that initiates base excision repair by recognizing and excising oxidized DNA lesions, including damaged pyrimidines, and processing abasic sites to promote strand incision. It functions within oxidative stress response and genome maintenance pathways, coordinating with downstream BER enzymes to restore DNA integrity during replication and transcription. NEIL1 activity influences mutation accumulation and chromosomal stability, linking its dysregulation to mechanisms underlying carcinogenesis and other disorders associated with oxidative DNA damage. As a nuclear repair factor, NEIL1 is frequently studied in the context of replication-associated repair, mitochondrial/nuclear genome stability, and cellular responses to reactive oxygen species.
NEIL1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NEIL1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NEIL1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NEIL1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NEIL1 protein expression.
This CRISPR knockout system enables efficient generation of NEIL1-deficient cell models for investigation of NEIL1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.